Mad proteins contain a dominant transcription repression domain

Transcription repression by the basic region-helix-loop-helix-zipper (bHLHZip) protein Mad1 requires DNA binding as a ternary complex with Max and mSin3A or mSin3B, the mammalian orthologs of the Saccharomyces cerevisiae transcriptional corepressor SIN3. The interaction between Mad1 and mSin3 is mediated by three potential amphipathic alpha-helices: one in the N terminus of Mad (mSin interaction domain, or SID) and two within the second paired amphipathic helix domain (PAH2) of mSin3A. Mutations that alter the structure of the SID inhibit in vitro interaction between Mad and mSin3 and inactivate Mad's transcriptional repression activity. Here we show that a 35-residue region containing the SID represents a dominant repression domain whose activity can be transferred to a heterologous DNA binding region. A fusion protein comprising the Mad1 SID linked to a Ga14 DNA binding domain mediates repression of minimal as well as complex promoters dependent on Ga14 DNA binding sites. In addition, the SID represses the transcriptional activity of linked VP16 and c-Myc transactivation domains. When fused to a full-length c-Myc protein, the Mad1 SID specifically represses both c-Myc's transcriptional and transforming activities. Fusions between the GAL DNA binding domain and full-length mSin3 were also capable of repression. We show that the association between Mad1 and mSin3 is not only dependent on the helical SID but is also dependent on both putative helices of the mSin3 PAH2 region, suggesting that stable interaction requires all three helices. Our results indicate that the SID is necessary and sufficient for transcriptional repression mediated by the Mad protein family and that SID repression is dominant over several distinct transcriptional activators.

[1]  P. Leder,et al.  An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. , 1992, Genes & development.

[2]  G. Prendergast,et al.  c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. , 1994, The EMBO journal.

[3]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[4]  H. Wang,et al.  In vitro regulation of a SIN3-dependent DNA-binding activity by stimulatory and inhibitory factors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[6]  Alexander D. Johnson,et al.  Ssn6-Tup1 is a general repressor of transcription in yeast , 1992, Cell.

[7]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Thorner,et al.  Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. , 1994, Genes & development.

[9]  R. Tjian,et al.  Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40 , 1987, Nature.

[10]  H. Jäckle,et al.  Control of transcription by Krüppel through interactions with TFIIB and TFIIEβ , 1995, Nature.

[11]  R. Roeder,et al.  The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. , 1990, Genes & development.

[12]  Roger Brent,et al.  Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins , 1994, Cell.

[13]  R. Eisenman,et al.  A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.

[14]  J. Manley,et al.  The transcriptional repressor even-skipped interacts directly with TATA-binding protein , 1995, Molecular and cellular biology.

[15]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[16]  N. DeLuca,et al.  Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB , 1995, Molecular and cellular biology.

[17]  J. Workman,et al.  Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. , 1994, Science.

[18]  R. Roeder,et al.  Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region , 1985, Cell.

[19]  P R Nicholson,et al.  The Saccharomyces cerevisiae SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs , 1990, Molecular and cellular biology.

[20]  M. Roussel,et al.  Inhibition of cell proliferation by the Mad1 transcriptional repressor , 1996, Molecular and cellular biology.

[21]  L. Larsson,et al.  Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. , 1994, Oncogene.

[22]  Richard A. Young,et al.  An RNA polymerase II holoenzyme responsive to activators , 1994, Nature.

[23]  Young-Sun Lin,et al.  GAL4 derivatives function alone and synergistically with mammalian activators in vitro , 1988, Cell.

[24]  S. Dorland,et al.  Epistasis analysis of suppressor mutations that allow HO expression in the absence of the yeast SW15 transcriptional activator. , 1994, Genetics.

[25]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[26]  R. Tjian,et al.  Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. , 1985, Science.

[27]  R. Eisenman,et al.  Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[28]  J. León,et al.  Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. , 1995, Oncogene.

[29]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[30]  C. Thompson,et al.  Association of an activator with an RNA polymerase II holoenzyme. , 1995, Genes & development.

[31]  R. Eisenman,et al.  Myc‐Max heterodimers activate a DEAD box gene and interact with multiple E box‐related sites in vivo. , 1996, The EMBO journal.

[32]  R. Roeder,et al.  Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression , 1996, Molecular and cellular biology.

[33]  A. Leutz,et al.  Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP‐1 and NF‐M, a myeloid specific, C/EBP‐like factor. , 1992, The EMBO journal.

[34]  Ian G. Cowell,et al.  Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain , 1994, Nucleic Acids Res..

[35]  H. Varmus,et al.  Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.

[36]  H. Wang,et al.  Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein , 1993, Molecular and cellular biology.

[37]  Fos and jun cooperate in transcriptional regulation via heterologous activation domains , 1990 .

[38]  R. DePinho,et al.  Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells , 1995, Nature Medicine.

[39]  B. Kirschbaum,et al.  Definition of the transcriptional activation domain of recombinant 43-kilodalton USF , 1992, Molecular and cellular biology.

[40]  Michael R. Green,et al.  Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex , 1994, Nature.

[41]  M. Carlson,et al.  The SNF/SWI family of global transcriptional activators. , 1994, Current opinion in cell biology.

[42]  David M. Chao,et al.  A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast , 1993, Cell.

[43]  D. Hanahan,et al.  Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. , 1995, Oncogene.

[44]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[45]  R. Evans,et al.  A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.

[46]  Michael R. Green,et al.  Facilitated binding of TATA-binding protein to nucleosomal DNA , 1994, Nature.

[47]  G. Evan,et al.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.

[48]  R. Bernards.  Transcriptional Regulation: Flipping the Myc switch , 1995, Current Biology.

[49]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[50]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[51]  Arthur R. Brothman,et al.  Mutation of the MXI1 gene in prostate cancer , 1995, Nature Genetics.

[52]  R. Eisenman,et al.  Transcriptional activities of the Myc and Max proteins in mammalian cells. , 1992, Current topics in microbiology and immunology.

[53]  N. Copeland,et al.  Mad3 and Mad4: novel Max‐interacting transcriptional repressors that suppress c‐myc dependent transformation and are expressed during neural and epidermal differentiation. , 1995, The EMBO journal.

[54]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[55]  K. Alitalo,et al.  Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.

[56]  Bruno Amati,et al.  Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.

[57]  L. Chin,et al.  Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. , 1996, Oncogene.

[58]  K. Struhl,et al.  Distinct TPR motifs of Cyc8 are involved in recruiting the Cyc8-Tup1 corepressor complex to differentially regulated promoters. , 1995, Genes & development.

[59]  W. Gu,et al.  Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Seelos,et al.  Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. , 1995, Oncogene.

[61]  R. DePinho,et al.  Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Eisenman,et al.  Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.

[63]  K. Struhl,et al.  Functional dissection of the yeast Cyc8–Tupl transcriptional co-repressor complex , 1994, Nature.

[64]  M. Eilers,et al.  The functions of Myc proteins. , 1992, Biochimica et biophysica acta.

[65]  D. Stillman,et al.  Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S Gaubatz,et al.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.

[67]  M. Carlson,et al.  Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Roeder,et al.  Fos and jun cooperate in transcriptional regulation via heterologous activation domains , 1990, Molecular and cellular biology.

[69]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[70]  M. Carlson,et al.  SSN genes that affect transcriptional repression in Saccharomyces cerevisiae encode SIN4, ROX3, and SRB proteins associated with RNA polymerase II , 1996, Molecular and cellular biology.

[71]  D. Reinberg,et al.  Structure-function analysis of the TBP-binding protein Dr1 reveals a mechanism for repression of class II gene transcription. , 1994, Genes & development.

[72]  R. DePinho,et al.  Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[74]  M. Kasten,et al.  SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein , 1996, Molecular and cellular biology.

[75]  K. Alitalo,et al.  Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro , 1995, The Journal of cell biology.

[76]  R. DePinho,et al.  Myc and Max: a putative transcriptional complex in search of a cellular target. , 1992, Current opinion in cell biology.

[77]  R. DePinho,et al.  Erratum: Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells (Nature Medicine (1995) 1 (638-643)) , 1995 .

[78]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.